[Beta-thalassemia in a Danish family].

J. Bundgaard,L. Friis-Hansen

2002-03-25

Abstract:We report a case of beta-thalassaemia in a family of Danish origin, owing to a C to T substitution in codon 39 of the beta-globin gene.

What problem does this paper attempt to address?

FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

A. Deisseroth,C. Ko,L. Nie,J. F. Zirkelbach,Liang Zhao,J. Bullock,N. Mehrotra,P. D. Del Valle,H. Saber,Christopher M. Sheth,Brenda J Gehrke,R. Justice,A. Farrell,R. Pazdur

DOI: https://doi.org/10.1158/1078-0432.CCR-14-1678

IF: 13.801

2015-01-19

Clinical Cancer Research

Abstract:On April 22, 2014, the FDA granted full approval to siltuximab (SYLVANT for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody to IL6, for the treatment of patients with multicentric Castleman disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative. The approval was primarily based on the results of a randomized, double-blind trial in which 79 symptomatic patients with MCD were allocated (2:1) to siltuximab plus best supportive care (BSC) or to placebo plus BSC. The primary efficacy endpoint was the proportion of patients in each arm achieving a durable tumor and symptomatic response that persisted for a minimum of 18 weeks without treatment failure. Tumor response was based on independent review of CT scans using the revised Response Criteria for Malignant Lymphoma, and symptomatic response was defined as complete resolution or stabilization of 34 MCD-related signs and symptoms as reported by the investigator. Thirty-four percent of patients in the siltuximab arm and no patients in the placebo arm met the primary endpoint (P = 0.0012). The most common adverse reactions (>10% compared with placebo) during treatment with siltuximab were pruritus, increased weight, rash, hyperuricemia, and upper respiratory tract infection. Clin Cancer Res; 21(5); 950–4. ©2015 AACR.
Characterization of a novel 8.2 kb deletion causing beta-thalassemia

Ge Wang,Haoyang Huang,Li Chen,Qizhi Xiao,Wei Zhang,Qianqian Zhang

DOI: https://doi.org/10.1016/j.clinbiochem.2024.110832

2024-10-05

Abstract:Background: Thalassemia is a prevalent monogenic blood disorder, clinically classified into alpha- and beta-thalassemia, characterized by the imbalance of the alpha- and beta-globin chains that constitute adult hemoglobin. Copy number variations (CNVs) and single nucleotide variants in globin genes are the primary genetic defects causing thalassemia. Case report: During a prenatal examination, a pregnant woman was suspected to be a carrier of thalassemia, exhibiting microcytic hypochromic anemia and abnormal hemoglobin constituents. Gap-polymerase chain reaction (Gap-PCR) and reverse dot blot (PCR-RDB) techniques did not detect any common thalassemia mutations. We conducted hematological examination and further genetic analyses on the proband's family with three generations. Multiplex ligation-dependent probe amplification (MLPA) was employed to identify CNVs, targeted next-generation sequencing was used to screen for potential pathogenic variants, which were subsequently validated by Sanger sequencing. The hematological parameters of the proband, her father and her son all indicated they were beta-thalassemia carriers. MLPA results revealed a large deletion in beta-globin cluster. Further investigation confirmed the presence of a novel 8.2 kb deletion (NC_000011.10:g.5224208_5232469del) in the proband, her father, and her son, specifically covering the entire HBB gene while not impacting other globin genes. Conclusion: We found a novel 8.2 kb deletion leading to beta-thalassemia in a Chinese family in which three generations had been affected. This novel deletion may broaden the spectrum of known mutations in thalassemia and provide a reference for clinically suspected cases.
Single-session supine bilateral percutaneous nephrolithotomy.

S. Proietti,G. Sortino,A. Giannantoni,M. Sofer,R. Peschechera,L. Luciani,G. Morgia,G. Giusti

DOI: https://doi.org/10.1016/j.urology.2014.10.036

IF: 2.633

2015-02-01

Urology

Abstract:
Effects of chemical and enzymatic modifications on starch-oleic acid complex formation.

E. Arijaje,Ya‐Jane Wang

DOI: https://doi.org/10.1021/acs.jafc.5b00125

IF: 6.1

2015-04-21

Journal of Agricultural and Food Chemistry

Abstract:The solubility of starch-inclusion complexes affects the digestibility and bioavailability of the included molecules. Acetylation with two degrees of substitution, 0.041 (low) and 0.091 (high), combined without or with a β-amylase treatment was employed to improve the yield and solubility of the inclusion complex between debranched potato starch and oleic acid. Both soluble and insoluble complexes were recovered and analyzed for their degree of acetylation, complexation yields, molecular size distributions, X-ray diffraction patterns, and thermal properties. Acetylation significantly increased the amount of recovered soluble complexes as well as the complexed oleic acid in both soluble and insoluble complexes. High-acetylated debranched-only starch complexed the highest amount of oleic acid (38.0 mg/g) in the soluble complexes; low-acetylated starch with or without the β-amylase treatment resulted in the highest complexed oleic acid in the insoluble complexes (37.6-42.9 mg/g). All acetylated starches displayed the V-type X-ray pattern, and the melting temperature generally decreased with acetylation. The results indicate that starch acetylation with or without the β-amylase treatment can improve the formation and solubility of the starch-oleic acid complex.
Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia

M. Mamata,G. Padma,T. Pragna Laxmi,K. Saroja,Dalal Ashwin,Jain Suman

DOI: https://doi.org/10.1080/03630269.2023.2279609

2024-01-24

Hemoglobin

Abstract:A 21-year-old patient presented with a previous medical history of pallor, mild icterus, increased fatigue, low hemoglobin, and abnormal hemoglobin variant analysis with more than 70 transfusions. He was referred for genetic analysis to identify the pathogenic variations in the β-globin gene. Sanger's sequencing of the proband and his family revealed the presence of a novel frame shift variant HBB:c.163delG in a compound heterozygous state with hemoglobin E (HbE) (HBB:c.79G > A) variant. The father and the sibling of the patient were found to be normal for the HBB gene. Mother was found to be heterozygous for HbE (HBB:c.79G > A ) variant. In silico analysis by Mutalyzer predicted that c.163delG variant generated a premature stop codon after seven codons, leading to a truncated protein. FoldX protein stability analysis showed a positive ΔΔG value of 45.27 kcal/mol suggesting a decrease in protein stability. HBB : c.79G > A is a known variant coding for HbE variant, which results in the reduced synthesis of β-globin chain and shows mild thalassemia. Combined effect of HBB:c.163delG and HBB:c.79G > A variants in the proband might have led to the reduced synthesis of β-globin chains resulting in a thalassemia intermedia type of clinical manifestation.

biochemistry & molecular biology,hematology
Hemoglobinopathy gone astray—three novel forms of α-thalassemia in Norwegian patients characterized by quantitative real-time PCR and DNA sequencing

Runa M. Grimholt,Bente Fjeld,Olav Klingenberg

DOI: https://doi.org/10.1080/00365513.2021.2004218

2021-11-18

Scandinavian Journal of Clinical and Laboratory Investigation

Abstract:α-thalassemia is one of the most common monogenic diseases worldwide and is caused by reduced or absent synthesis of α-globin chains, most commonly due to deletions of one or more of the α-globin genes. α-thalassemia occurs with high frequency in tropical and subtropical regions of the world and are very rarely found in the indigenous Scandinavian population. Here, we describe four rare forms of α-thalassemia out of which three are novel, found in together 20 patients of Norwegian origin. The study patients were diagnosed during routine hemoglobinopathy evaluation carried out at the Department of Medical Biochemistry, Oslo University Hospital, Norway. The patients were selected for their thalassemic phenotype, despite Norway as country of origin. All samples went through standard hemoglobinopathy evaluation. DNA sequencing and copy number variation (CNV) analysis using quantitative real-time polymerase chain reaction (qPCR) was applied to detect sequence variants and uncommon deletions in the α-globin gene cluster, respectively. Deletion breakpoints were characterized using gap-PCR and DNA sequencing. DNA sequencing revealed a single nucleotide deletion in exon 3 of the HBA2 gene (NM_000517.4(HBA2):c.345del) and a novel deletion of 20 nucleotides in exon 2 of the HBA2 gene (NM_000517.4(HBA2):c.142_161del). qPCR CNV analysis detected two novel large deletions in the α-globin gene cluster, -(NOR) deletion covering both α-globin genes and (αα)Aurora Borealis affecting the regulatory region, leaving the downstream α-globin genes intact. Even though inherited globin gene disorders are extremely rare in indigenous Scandinavians, the possibility of a carrier state should not be ignored.

medicine, research & experimental
Treatment of exposure to chemical personal protection agents.

B. Lee,R. Knopp,M. Richardson

DOI: https://doi.org/10.1016/S0196-0644(84)80041-4

IF: 6.762

1984-06-01

Annals of Emergency Medicine

Abstract:
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia

Jyoti Shaw,Abhilipsa Patra,Anjumana Khatun,Rudra Ray,Amit Ghosh,Sonali Mahapatra,Ashutosh Panigrahi,Maitreyee Bhattacharyya

DOI: https://doi.org/10.1002/jha2.923

2024-05-27

eJHaem

Abstract:The phenotype of β-thalassemia varies widely. The primary determinant is the type of beta-globin gene mutation; however, there are secondary and tertiary modifiers also as associated alpha mutations, polymorphisms, as well as coinheritance of mutations affecting other related systems. Co-inheritance of alpha thalassemia mutations is known to ameliorate the severity of HbE-β thalassemia. However, the role of alpha globin gene alterations (deletions and triplication) is not well illustrated in homozygous β-thalassemia. Here we evaluated the role of alpha globin gene alterations in 122 β-thalassemia patients having IVS1-5 (G > C) homozygous mutation. β-thalassemia mutations were detected by ARMS PCR and alpha mutations by GAP-PCR. Gene expression by qRT-PCR. Out of 122 cases, 15 patients had alpha 3.7 triplications (ααα3.7anti), 24 had alpha 3.7 kb deletion (-α3.7) mutation and three patients had 4.2 kb deletion (-α4.2). Patients were divided into two groups, requiring less than 8 units (NTDT) and more than 8 units (TDT) of blood transfusion per year (≥8U BT/year). The percentage of alpha deletion was significantly (p = 0.0042) high in NTDT (42.1%) as compared with TDT (13.2%). Conversely, the proportion of alpha triplication is high in the TDT as compared with NTDT. Even mean serum ferritin level was found to be significantly high in patients having alpha triplication as compared with those having alpha deletions (p = 0.0184) and normal alpha gene (p = 0.0003). α/β globin ratio was highest in TDT patients with alpha triplication and lowest in NTDT patients with alpha-del. The results show that concurrent inheritance of alpha gene alterations influences the phenotypic severity of homozygous β-thalassemia.
β0-Thalassemia Caused by a Novel Nonsense Mutation

John S. Waye,Meredith Hanna,Betty-Ann Hohenadel,Lisa Nakamura,Lynda Walker,Barry Eng,Landry E. Nfonsam,John S. WayeMeredith HannaBetty-Ann HohenadelLisa NakamuraLynda WalkerBarry EngLandry E. Nfonsama Molecular Genetics Laboratory,Hamilton Regional Laboratory Medicine Program,Hamilton Health Sciences,Hamilton,Ontario,Canadab Department of Pathology and Molecular Medicine,McMaster University,Hamilton,Ontario,Canada

DOI: https://doi.org/10.1080/03630269.2024.2322518

2024-03-02

Hemoglobin

Abstract:We report two hemoglobinopathy cases involving a novel β-thalassemia (β-thal) nonsense mutation, HBB: c.199A > T. One patient had Hb S/β-thal, and a second unrelated patient had Hb D-Punjab/β-thal. The HBB: c.199A > T mutation introduces a premature termination codon at amino acid codon 66 (AAA→TAA) in exon 2, resulting in typical high Hb A 2 β 0 -thal.

biochemistry & molecular biology,hematology
Compound heterozygosity for two new mutations in the beta-globin gene [codon 9 (+TA) and polyadenylation site (AATAAA-->AAAAAA)] leads to thalassemia intermedia in a Tunisian patient

Aurelia Jacquette,Geneviève Le Roux,Chantal Lacombe,Michel Goossens,Serge Pissard

DOI: https://doi.org/10.1081/hem-120040304

Hemoglobin

Abstract:More than 200 mutations that are associated with beta-thalassemia (thal) have been found. In most cases, studies to detect a mutation in a patient is made easier because of the existence of geographical sets of mutations that allow the use of a dedicated mutation detection kit. We describe here a patient who originated from Tunisia, in whom we found two as yet unreported mutations, showing that even in a well-studied population a full gene study might be needed to characterize mutation(s).
Hb A2-Pasteur-Tunis [delta59(E3)Lys-->Asn, AAG-->AAC]: a new delta chain variant detected by DNA sequencing in a Tunisian carrier of the codon 39 (C-->T) beta0-Thalassemia mutation

Imen Moumni,Amine Zorai,Bechir Ben Daoued,Ikbel Mosbahi,Souheil Omar,Neziha Kaabachi,Koussay Dellagi,Salem Abbes

DOI: https://doi.org/10.1080/03630260601057005

Hemoglobin

Abstract:We describe a new delta-globin variant, Hb A2-Pasteur-Tunis [delta59(E3)Lys-->Asn, AAG-->AAC]. This hemoglobin (Hb) displayed an electrophoretic mobility faster than normal Hb A2 and was expressed at 2.2 %. The molecular defect was characterized by DNA sequencing and confirmed by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)-designed protocol. Hb A2-Pasteur-Tunis was found in a carrier of a codon 39 (C-->T) beta0-thalassemia (thal), presenting with a normal Hb A2 level. Phenotype and genotype investigations revealed that the total Hb A2 level of the patient was that expected for a minor beta-thal (4.8%).
Unravelling the Complexity of the +33 C>G [HBB:c.-18C>G] Variant in Beta Thalassemia

Coralea Stephanou,Miranda Petrou,Petros Kountouris,Christiana Makariou,Soteroula Christou,Michael Hadjigavriel,Marina Kleanthous,Thessalia Papasavva

DOI: https://doi.org/10.3390/biomedicines12020296

IF: 4.757

2024-01-27

Biomedicines

Abstract:The +33 C>G variant [NM_000518.5(HBB):c.-18C>G] in the 5′ untranslated region (UTR) of the β-globin gene is described in the literature as both mild and silent, while it causes a phenotype of thalassemia intermedia in the presence of a severe β-thalassemia allele. Despite its potential clinical significance, the determination of its pathogenicity according to established standards requires a greater number of published cases and co-segregation evidence than what is currently available. The present study provides an extensive phenotypic characterization of +33 C>G using 26 heterozygous and 11 compound heterozygous novel cases detected in Cyprus and employs computational predictors (CADD, RegulomeDB) to better understand its impact on clinical severity. Genotype identification of globin gene variants, including α- and δ-thalassemia determinants, and rs7482144 (XmnI) was carried out using Sanger sequencing, gap-PCR, and restriction enzyme digestion methods. The heterozygous state of +33 C>G had a silent phenotype without apparent microcytosis or hypochromia, while compound heterozygosity with a β+ or β0 allele had a spectrum of clinical phenotypes. Awareness of the +33 C>G is required across Mediterranean populations where β-thalassemia is frequent, particularly in Cyprus, with significant relevance in population screening and fetal diagnostic applications.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
A Novel Mutation at HBA1: c.349G>T Causing α-Thalassemia in a Chinese Family

Zhenzhen Yin,Yuqi Hao,Xiaoyan Huang,Xiaohang Chen,Shiping Chen,Gaochi Li,Chuyan Chen,Fengxiang Wei

DOI: https://doi.org/10.1080/03630269.2021.1925292

Hemoglobin

Abstract:α-Thalassemia (α-thal) is one of the most common genetic diseases in Southern China. Although more than 300 α-thal mutations have been reported in the world, the mutation spectrum is still not comprehensive. In this study, a novel mutation (HBA1: c.349G>T) in a newborn (proband) was first found by next-generation sequencing (NGS). Subsequently, hematological analysis and thalassemia genetic testing were performed for the family members. The results showed that both the proband and her mother were heterozygotes for this novel mutation and presented abnormal hematological indices. Based on the features observed in clinical practice, this novel mutation was considered as a type of α-thal variation.
Newborn Screening for β-Thalassemia Identifies a Complex Genotype Involving a Novel β-Globin Gene Mutation (HBB:c.336dup)

John S. Waye,Meredith Hanna,Betty-Ann Hohenadel,Lisa Nakamura,Lynda Walker,Barry Eng,Landry E. Nfonsam

DOI: https://doi.org/10.1080/03630269.2024.2328220

2024-04-03

Hemoglobin

Abstract:Newborn screening identified a Chinese-Canadian infant who was positive for possible β-thalassemia (β-thal). Detailed family studies demonstrated that the proband was a compound heterozygote for the Chinese G γ( A γδβ) 0 -thal deletion and a novel frameshift mutation within exon 3 ( HBB :c.336dup), and heterozygous for the Southeast Asian α-thal deletion (−− SEA /αα). This case illustrates the importance of follow-up molecular testing of positive newborn screening results to confirm the diagnosis and define risks for future pregnancies.

biochemistry & molecular biology,hematology
Beta‐thalassemia intermedia due to a complex alpha‐globin rearrangement and a heterozygous beta thalassemia mutation

Victor Marin,Yoann Huguenin,Lucile Bessi,Laurent Weinmann,Vanessa Augis,Arnaud Desclaux,Louis Lebreton,Stephanie Dulucq,Julian Boutin

DOI: https://doi.org/10.1111/bjh.19715

2024-08-19

British Journal of Haematology

Abstract:Summary The alpha‐thalassaemia alleles are very frequent in the world's population. The main molecular mechanism is a large deletion with the loss of one or two alpha genes. Another type of rarer abnormality exists: the gain of alpha genes. The consequence of a gain is an overproduction of alpha‐globin chains, which aggravates a beta‐thalassaemia trait into an intermedia phenotype (non‐transfusion‐dependent thalassaemia, NTDT). Here, we report the case of a young girl referred for a beta‐NTDT with a combination never described in the literature: a heterozygous beta‐thalassaemia mutation associated with a copy number gain of the alpha‐globin locus and ‐alpha 3.7 deletion on the same allele.

hematology
Identification of a Novel 7-Bp Deletion in the Α-Globin Gene Cluster in One Chinese Family.

Bo-Dan Wu,Xiao-Yan Zhou,Mei-Juan Xie,Chan-Chan Jin,Yuan-Long Yan,Jing He,Bao-Sheng Zhu,Jie Zhang

DOI: https://doi.org/10.1080/03630269.2023.2216890

2023-01-01

Hemoglobin

Abstract:Deletional α-thalassemia is characterized by reduced hemoglobin A2 and involves the deletion of a few nucleotides, which is a rare hereditary disease. However, the detection of rare mutations using commonly used genetic tests is highly challenging. In the present study, next-generation sequencing (NGS) was used to identify a novel 7-bp deletion α-thalassemia in one individual from a Chinese family. Hematological parameters of the family members were determined using an automated cell counter, and hemoglobin electrophoresis was performed using a capillary electrophoresis system. Subsequently, NGS was performed on the genomic DNA of the patient and her family members. The 7-bp deletion (named Hb Honghe [HBA1: c.401_407delGCACCGT]) of α-thalassemia in the α-globin gene was confirmed using Sanger sequencing. The patient's father was also a heterozygous carrier of HBA1: c.401_407delGCACCGT deletion, but not her mother or sister. The application of the combined molecular approach is essential for the accurate diagnosis of rare thalassemia. This study reports a novel case of α- thalassemia. The characterization of the mutation might provide new insights into genetic counseling and accurate diagnosis of thalassemia.
Immunoadsorption as treatment option in dilated cardiomyopathy

S. Felix,A. Staudt

DOI: https://doi.org/10.1080/08916930802031173

IF: 3.5

2008-01-01

Autoimmunity

Abstract:Abnormalities of the cellular and humoral immune system have been described in patients with dilated cardiomyopathy (DCM). Various circulating cardiac autoantibodies have been detected among DCM patients. Circulating antibodies are extractable by immunoadsorption (IA). Recent open controlled pilot studies have consequently shown that removal of circulating antibodies by IA induces improvement of cardiac function in DCM. IA, furthermore, decreases myocardial inflammation. In vitro data indicate that cardiodepressive antibodies play an important role in cardiac dysfunction of DCM patients; removal of these antibodies may accordingly represent the essential mechanism of IA in DCM. Furthermore, detection of cardiodepressive antibodies predicts hemodynamic benefits during IA. These antibodies belong to immunoglobulin G subclass 3. Recent data indicate that newly detected sarcolemmal Fcγ receptors IIa are involved in the functional effects of cardiac autoantibodies.
Light and Temperature Cycles as Zeitgebers of Zebrafish (Danio rerio) Circadian Activity Rhythms

J. López-Olmeda,J. Madrid,F. Sánchez‐Vázquez

DOI: https://doi.org/10.1080/07420520600651065

2006-01-01

Chronobiology International

Abstract:Light and temperature cycles are the most important synchronizers of biological rhythms in nature. However, the relative importance of each, especially when they are not in phase, has been poorly studied. The aim of this study was to analyze the entrainment of daily locomotor activity to light and/or temperature cycles in zebrafish. Under two constant temperatures (20°C and 26°C) and 12:12 light-dark (LD) cycles, zebrafish were most active during the day (light) time and showed higher total activity at the warmer temperature, while diurnalism was higher at 20°C than at 26°C (87% and 77%, respectively). Under thermocycles (12:12 LD, 26:20°C thermophase:chryophase or TC), zebrafish daily activity synchronized to the light phase, both when the thermophase and light phase were in phase (LD/TC) or in antiphase (LD/CT). Under constant dim light (3 lux), nearly all zebrafish synchronized to thermocycles (τ=24 h), although activity rhythms (60% to 67% of activity occurred during the thermophase) were not as marked as those observed under the LD cycle. Under constant dim light of 3 lux and constant temperature (22.5°C), 4 of 6 groups of zebrafish previously entrained to thermocycles displayed free‐running rhythms (τ=22.9 to 23.6 h). These results indicate that temperature cycles alone can also entrain zebrafish locomotor activity.
Case report: Identification of a novel triplication of alpha-globin gene by the third-generation sequencing: pedigree analysis and genetic diagnosis

Yujiao Chen,Tiantian Xie,Minhui Ma,Juan Yang,Yihang Lv,Xudong Dong

DOI: https://doi.org/10.1080/16078454.2023.2277571

IF: 2.264

Hematology

Abstract:Background: Thalassemia, a common autosomal hereditary blood disorder worldwide, mainly contains α- and β-thalassemia. The α-globin gene triplicates allele is harmless for carriers, but aggravates the phenotype of β-thalassemia. Therefore, it is particularly crucial to accurately detect the structural variants of α-globin gene clusters. Case report: We reported a 28-year-old man, the proband, with microcytic hypochromic anemia. From pedigree analysis, his mother and sister had hypochromic microcytosis, and his father was normal. Genetic testing of thalassemia identified a novel α-globin gene triplicate named αααanti4.2del726bp (NC_000016.10:g.170769_174300dupinsAAAAAA) by third-generation sequencing (TGS) in the proband and his father, which was further validated by multiplex ligation-dependent probe amplification (MLPA) and Sanger sequencing. The genotypes of the proband's mother and sister were both -α3.7/αα compounded with heterozygous HBB:c.126_129delCTTT. They were categorized as silent α-thalassemia with co-inheritance of β-thalassemia trait. The proband's genotype additionally had the α-globin gene triplicates compared with his mother and sister, which increased the imbalance between α/β-globin, so the proband had more severe hematological parameters. The proband's wife was diagnosed as HBA2:c.427T > C heterozygosis, and his daughter had the novel α-globin gene triplicates compounded with HBA2:c.427T > C, therefore the girl might be asymptomatic. Conclusion: The identification of the novel α-globin gene triplicates provides more insight for the research of thalassemia variants and indicates that TGS has signiﬁcant advantages on genetic testing of thalassemia for the reliability, accuracy and comprehensiveness.
Heterozygous Beta‐Thalassaemia in Pregnancy: Two Rare Causes of Severe Fetal Anemia Requiring Intrauterine Blood Transfusions

Eva van der Meij,Frans J. W. Smiers,Tamara T. Koopmann,Ingrid Krapels,Kaatje LePoole,Enrico Lopriore,Johanna M. Middeldorp,Claudia S. Ootjers,Volkher Scharnhorst,Hubertina C. J. Scheepers,Cornelis L. Harteveld,E. J. T. (Joanne) Verweij

DOI: https://doi.org/10.1002/pd.6695

2024-11-04

Prenatal Diagnosis

Abstract:Aim In this article, we present two cases of severe fetal hemolytic anemia based on a beta‐thalassaemia trait inherited from a single parent. Results These cases, presented at 20 and 28 weeks' gestation, necessitated intra‐uterine blood transfusions. This occurrence is remarkable because it challenges the common assumption that beta‐thalassaemia typically has no prenatal implications regarding fetal anemia. Both fetuses inherited a rare heterozygous mutation from their mother, resulting in gamma‐thalassaemia‐related anemia. In the first case, the anemia was related to a deletion in the beta locus control region (βLCR) and in the second case, a deletion on chromosome 11p15.4 was the cause. These mutations not only affect the beta chain production, but also the gamma chain production, leading to a reduction in the synthesis of HbF, ineffective erythropoiesis and consequently, perinatal hemolytic anemia. Conclusion Clinicians should be vigilant regarding these rare mutations in families with a history of beta‐thalassaemia as the fetal clinical consequences can be severe and intra‐uterine blood transfusions may prove life‐saving for these fetuses.

genetics & heredity,obstetrics & gynecology

[Beta-thalassemia in a Danish family].

FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

Characterization of a novel 8.2 kb deletion causing beta-thalassemia

Single-session supine bilateral percutaneous nephrolithotomy.

Effects of chemical and enzymatic modifications on starch-oleic acid complex formation.

Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia

Hemoglobinopathy gone astray—three novel forms of α-thalassemia in Norwegian patients characterized by quantitative real-time PCR and DNA sequencing

Treatment of exposure to chemical personal protection agents.

Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia

β0-Thalassemia Caused by a Novel Nonsense Mutation

Compound heterozygosity for two new mutations in the beta-globin gene [codon 9 (+TA) and polyadenylation site (AATAAA-->AAAAAA)] leads to thalassemia intermedia in a Tunisian patient

Hb A2-Pasteur-Tunis [delta59(E3)Lys-->Asn, AAG-->AAC]: a new delta chain variant detected by DNA sequencing in a Tunisian carrier of the codon 39 (C-->T) beta0-Thalassemia mutation

Unravelling the Complexity of the +33 C>G [HBB:c.-18C>G] Variant in Beta Thalassemia

A Novel Mutation at HBA1: c.349G>T Causing α-Thalassemia in a Chinese Family

Newborn Screening for β-Thalassemia Identifies a Complex Genotype Involving a Novel β-Globin Gene Mutation (HBB:c.336dup)

Beta‐thalassemia intermedia due to a complex alpha‐globin rearrangement and a heterozygous beta thalassemia mutation

Identification of a Novel 7-Bp Deletion in the Α-Globin Gene Cluster in One Chinese Family.

Immunoadsorption as treatment option in dilated cardiomyopathy

Light and Temperature Cycles as Zeitgebers of Zebrafish (Danio rerio) Circadian Activity Rhythms

Case report: Identification of a novel triplication of alpha-globin gene by the third-generation sequencing: pedigree analysis and genetic diagnosis

Heterozygous Beta‐Thalassaemia in Pregnancy: Two Rare Causes of Severe Fetal Anemia Requiring Intrauterine Blood Transfusions